Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging

Nature Medicine

Volumn 13, Issue 1, 2007, Pages 95-99

  Lee, Jae Hyun ^a   Huh, Yong Min ^b   Jun, Young Wook ^a   Seo, Jung Wook ^a   Jang, Jung Tak ^a   Song, Ho Taek ^b   Kim, Sungjun ^b   Cho, Eun Jin ^b   Yoon, Ho Geun ^b   Suh, Jin Suck ^b   Cheon, Jinwoo ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; COPPER IRON OXIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FERRIC OXIDE; MANGANESE IRON OXIDE; MANGANESE IRON OXIDE HERCEPTIN CONJUGATE; NICKEL IRON OXIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ENGINEERING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMAGE ENHANCEMENT; MAGNETISM; MOLECULAR IMAGING; MOUSE; NANOPROBE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL LINE, TUMOR; FEMALE; FERRIC COMPOUNDS; HELA CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846090375     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1467     Document Type: Article

References (25)

1. Graves, E.E., Weissleder, R. & Ntziachristos, V. Fluorescence molecular imaging of small animal tumor models. Curr. Mol. Med. 4, 419-430 (2004).
2. Larson, D.R. et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300, 1434-1436 (2003).
3. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W.K. & Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976 (2004).
4. Kim, S. et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22, 93-97 (2004).
5. Czernin, J. & Phelps, M.E. Positron emission tomography scanning: current and future applications. Annu. Rev. Med. 53, 89-112 (2002).
6. McDonald, D.M. & Choyke, P.L. Imaging of angiogenesis: from microscope to clinic. Nat. Med. 9, 713-725 (2003).
7. Josephson, L., Tung, C.H., Moore, A. & Weissleder, R. High-efficiency intracellular magnetic labelling with novel superparamagnetic-tat peptide conjugates. Bioconjug. Chem. 10, 186-191 (1999).
8. Bulte, J.W. et al. Magnetodendrimers allow endosomal magnetic labelling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141-1147 (2001).
9. Weissleder, R. et al. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351-355 (2000).
10. Kang, H.W., Josephson, L., Petrovsky, A., Weissleder, R. & Bogdanov, A., Jr. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug. Chem. 13, 122-127 (2002).
11. Zhao, M., Beauregard, D.A., Loizou, L., Davletov, B. & Brindle, K.M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 7, 1241-1244 (2001).
12. Jun, Y-w. et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 127, 5732-5733 (2005).
13. Huh, Y.-M. et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc. 127, 12387-12391 (2005).
14. Artemov, D., Mori, N., Okollie, B. & Bhujwalla, A.M. MR molecular imaging of the HER-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med. 49, 403-408 (2003).
15. Allen, M.J. & Meade, T.J. Magnetic resonance contrast agents for medical and molecular imaging. Met. Ions Biol. Syst. 42, 1-38 (2004).
16. Benaron, D.A. The future of cancer imaging. Cancer Metastasis Rev. 21, 45-78 (2002).
17. Marks, V. Molecular imaging. Chem. Eng. News 83, 25-34 (2005).
18. Bulte, J.W. & Kraitchman, D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484-499 (2004).
19. Cheon, J., Seo, J.-w. & Lee, J.-H. Preparation method of magnetic and metal oxide nanoparticles. Korea Patent PCT WO2006/052042 (2004).
20. McCurrie, R.A. Ferrimagnetic materials. in Ferromagnetic Materials 1st edn. Ch. 4, 123-134 (Academic Press, New York, 1994).
21. Koenig, S.H. & Kellar, K.E. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn. Reson. Med. 34, 227-233 (1995).
22. Hermanson, G.T. Heterobifunctional cross-linkers. in Bioconjugate Techniques 1st edn. Ch. 5, 235-237 (Academic Press, New York, 1996).
23. Hudziak, R.M. et al. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9, 1165-1172 (1989).
24. Vernimmen, D., Gueders, M., Pisvin, S., Delvenne, P. & Winkler, R. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. Br. J. Cancer 89, 899-906 (2003).
25. Sharkey, R.M. et al. Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat. Med. 11, 1250-1255 (2005).